Kevin F. Gibson
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes (NCT02134717) | Kevin F. Gibson | 2014-01-01 |
Track Kevin F. Gibson automatically
Every clearance here is in the API, with alerts when new ones post.